Ins and Outs

February 18th, 2009 News

  • A Health-Tech Monopoly… [WSJ]
  • Stem cell ‘cure’ boy gets tumour … [BBC]
    Paper: Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient PLoS Medicine Vol. 6, No. 2, e29 doi:10.1371/journal.pmed.1000029
  • FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events… [FDA]
  • MRSA Infection Rates Drop in Intensive-Care Units … [WSJ]
  • Researchers Explore New Driver of Transplant Rejection: Platelets… [Johns Hopkins]
  • Ultrasonication of nanotubes problematic in some nanomedical applications… [Nanowerk]
  • Survey of Metabolites Finds New Prostate Cancer Marker… [HHMI]
  • Disease management becoming a consumer market… [ZDNet Healthcare]
  • Philips Chief Medical Officer calls for reformation and reaffirmation to drive health care… [Philips ]
  • St. Jude Medical Welcomes Introduction of Legislation to Help People Suffering From Pain… [St. Jude Medical]
  • Monitoring Cell-Wide Protein Production with Ribosome Profiling… [HHMI]
  • Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion… [Nature Clinical Practice Urology]
  • Varying Sweat Scents Are Noted by Women… [NYTimes]

    • Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

    © Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.